InvestorsHub Logo
Followers 2
Posts 133
Boards Moderated 0
Alias Born 03/13/2013

Re: StockFollower post# 8745

Monday, 04/14/2014 3:30:15 PM

Monday, April 14, 2014 3:30:15 PM

Post# of 698564
IMO, the German approval is based on a perfect safety record and some evidence that the treatment is efficacious. That's it...well that and NWBO successfully jumped through all of the hoops that the Germans laid out.

Remember IMUC? They also had astonishing data indicating their treatment was efficacious. We both know that the trial did not exactly hit it out of the park.

However, I haven't written off IMUC either and hold a very small position that I bought after it crashed and after hearing more on the results. The more on the results was that there was some indication that the trial did show a statistically significant increase in PFS and maybe later OS too.

Do you think those that receive treatment in Germany will not also be seeking other treatments? This could be a win for looking at results of combining DCVax with other therapies.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News